Filings

Finds words inside filing documents. Searching MADRIGAL PHARMACEUTICALS, INC.'s filings · 59 documents indexed.

6 documents · 14 matches

MDGL MADRIGAL PHARMACEUTICALS, INC. 10-Q 2026-11-03

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
tariffs, pricing policies or other restrictions imposed by the United States government or governments of other nations, may have an adverse
2 matches in this document
MDGL MADRIGAL PHARMACEUTICALS, INC. 10-Q 2026-07-30

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
tariffs, pricing policies or other restrictions imposed by the United States government or governments of other nations, may have an adverse
2 matches in this document
MDGL MADRIGAL PHARMACEUTICALS, INC. 10-Q 2026-05-06

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
tariffs, pricing policies or other restrictions imposed by the United States government or governments of other nations, may have an adverse
2 matches in this document
MDGL MADRIGAL PHARMACEUTICALS, INC. 10-Q 2025-11-04

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
tariffs or other restrictions imposed by the United States government or governments of other nations, may have an adverse effect
2 matches in this document
MDGL MADRIGAL PHARMACEUTICALS, INC. 10-Q 2025-08-05

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
tariffs or other restrictions imposed by the United States government or governments of other nations, may have an adverse effect
2 matches in this document
MDGL MADRIGAL PHARMACEUTICALS, INC. 10-K 2026-02-19

Item 1A. Risk Factors
tariffs on pharmaceuticals if such manufacturers do not reach agreements to implement MFN pricing. Further, in November 2025, the Centers
4 matches in this document

Page 1 of 1 · 6 documents